---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-091486"
form_type: "8-K"
ticker: "ALHC"
cik: "0001832466"
company_name: "Alignment Healthcare, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:47:36.189455+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Selling stockholder sells 13.2M shares of Alignment Healthcare in underwritten offering via J.P. Morgan

## Summary
- Selling Stockholder sold 13,167,733 shares of common stock via J.P. Morgan Securities LLC.
- Offering closed March 4, 2026; company will not receive any proceeds from the sale.
- Shares offered under automatically effective Registration Statement on Form S-3ASR filed March 2, 2026.

## SEC filing metadata
- accession: 0001193125-26-091486
- form_type: 8-K
- ticker: ALHC
- cik: 0001832466
- company_name: Alignment Healthcare, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/0001193125-26-091486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/d46464d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-091486
- JSON: https://secwatch.observer/filing/0001193125-26-091486.json
- Plain text: https://secwatch.observer/filing/0001193125-26-091486.txt

## Key facts
- Material Agreements
  Alignment Healthcare, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto (effective 2026-03-02).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: J.P. Morgan Securities LLC and the selling stockholder listed on Schedule II thereto
  - Effective: 2026-03-02
  source text: On March 2, 2026, Alignment Healthcare, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC (the “Underwriter”) and the selling stockholder listed on Schedule II thereto (the “Selling Stockholder”) with respect to an underwritten offering by the Selling Stockholder of 13,167,733 shares (the “Shares”) of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832466/000119312526091486/0001193125-26-091486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.